Innate Pharma S.A. Sponsored ADR (IPHA)

Last Closing Price: 1.56 (2026-10-02)

Non-Operating Income/Expense (Quarterly)

Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.

Innate Pharma S.A. Sponsored ADR (IPHA) Non-Operating Income/Expense data is not available.

Figures for fiscal quarter ending 2026-06-30
Income Statement Financials
--
--
--
--
--
--
Non-Operating Income/Expense
--
--
--
--
--
--
--
--
--
--
--
--
--
Balance Sheet Financials
$22.79M
$4.24M
$17.59M
$40.38M
$38.20M
$10.95M
$49.27M
$87.47M
$-47.10M
$-47.10M
$-47.10M
93.92M
Cash Flow Statement Financials
$-24.47M
$2.36M
$-2.75M
$32.66M
$7.51M
$-25.15M
$1.25M
--
--
Fundamental Metrics & Ratios
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--